Global Pneumatic Nebulizers Market to Cross USD 875 Million By 2024

May 07, 2020

As per the report ‘Pneumatic Nebulizers Market Size By Product  Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024’, available with Market Study Report LLC, global pneumatic nebulizers market is projected to exceed USD 875 million by the year 2024.

Increasing prevalence of respiratory disorders owing to rising pollution levels and meteorological factors is driving the growth of global pneumatic nebulizers market. Technological advancements in pneumatic nebulizers such as integration of electronic display for monitoring patient’s breathing rate is enhancing the industry outlook. For instance, pneumatic nebulizers like Akita2 Apixneb offers highly efficient and advanced vibrating mesh which releases drug dosage only when the patient breaths properly.

Based on the product type, vented segment garnered USD 243.8 million in 2017 and is anticipated to grow considerably during the forecast period. Easy availability and high cost-effectiveness of vented pneumatic nebulizers are encouraging the product adoption. These nebulizers are compatible with a wide range of compressors.

Request sample copy of this Report:

As per the regional analysis, pneumatic nebulizers market in Canada is estimated to expand at 5.7% CAGR during the projection period. As per the report, chronic obstructive pulmonary disease (COPD) is the fourth leading factor of death. Increasing cases of COPD due to the severe smoking habit of Canadian population is bolstering the demand for pneumatic nebulizers.

On the other hand, Japan contributed 36.9% revenue share to APAC pneumatic nebulizers market in 2017. Increasing pollution levels, adoption of advanced products coupled with booming elderly population in the nation are expected to foster the industry growth in Japan over the forecast timeline.

Prominent players in global pneumatic nebulizers market include Aerogen Limited, Briggs Healthcare, Allied Healthcare Products, Inc., Becton, Dickinson and Company, OMRON Corporation, Heyer Medical AG, Philips Respironics, Inc., PARI Medical Holdings GmbH, TaiDoc Technology, and Salter Labs. These companies are engaged in novel product development, acquisitions, and collaborations in an effort to improve their market stance. For instance, in October 2016, Becton, Dickinson and Company declared a joint venture with Apax Partners to expand regional footprint in respiratory business.